Sanofi (0O59) Share Forecast & Price Target
0O59 Analyst Ratings
Moderate Buy
6Buy6Hold0Sell
Based on 12 analysts giving stock ratings to Sanofi in the past 3 months
0O59 Stock 12 Month Forecast
Average Price Target
EUR 93.10▲(16.36% Upside)Based on 12 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is EUR 93.10 with a high forecast of EUR 106.21 and a low forecast of EUR 78.00. The average price target represents a 16.36% change from the last price of EUR 80.01.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 106.21
AverageEUR 93.10
LowEUR 78.00
Highest Price TargetHighestEUR 106.21Average Price TargetEUR 93.10Lowest Price TargetLowestEUR 78.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | RBC Capital | EUR 75→EUR 80 | hold | -0.01%Downside | Reiterated | 11/02/26 | ||
| James Gordon CFA | Barclays | EUR 83→EUR 90 | hold | 12.49%Upside | Reiterated | 11/02/26 | ||
| Emmanuel Papadakis | Deutsche Bank | EUR 95 | buy | 18.74%Upside | Reiterated | 11/02/26 | ||
| Justin Smith | Bernstein | EUR 106.21 | buy | 32.75%Upside | Reiterated | 10/30/26 | ||
| Michael Leuchten | Jefferies | EUR 100 | buy | 24.98%Upside | Reiterated | 10/30/26 | ||
| Richard Vosser | J.P. Morgan | EUR 95 | hold | 18.74%Upside | Reiterated | 10/30/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | EUR 94 | buy | 17.49%Upside | Reiterated | 10/19/26 | ||
| Matthew Weston | UBS | EUR 78 | hold | -2.51%Downside | Reiterated | 10/15/26 | ||
| Sachin Jain | Bank of America Securities | EUR 92 | hold | 14.99%Upside | Reiterated | 10/08/26 | ||
| Luisa Hector | Berenberg Bank | EUR 105 | buy | 31.23%Upside | Reiterated | 10/05/26 | ||
| Rajesh Kumar | HSBC | EUR 95→EUR 100 | buy | 24.98%Upside | Reiterated | 09/10/26 | ||
| Sarita Kapila | Morgan Stanley | EUR 86→EUR 82 | hold | 2.49%Upside | Reiterated | 08/11/26 | ||
| Elmar Kraus | DZ BANK AG | ― | buy | ― | Reiterated | 07/31/26 | ||
| James Quigley | Goldman Sachs | EUR 89→EUR 84 | hold | 4.99%Upside | Reiterated | 07/06/26 | ||
| Nicolas Pauillac | Kepler Capital | EUR 85 | hold | 6.24%Upside | Reiterated | 04/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | 11/02/26 | EUR 75→EUR 80 | hold | -0.01%Downside | Reiterated | RBC Capital | ||
| James Gordon CFA | 11/02/26 | EUR 83→EUR 90 | hold | 12.49%Upside | Reiterated | Barclays | ||
| Emmanuel Papadakis | 11/02/26 | EUR 95 | buy | 18.74%Upside | Reiterated | Deutsche Bank | ||
| Justin Smith | 10/30/26 | EUR 106.21 | buy | 32.75%Upside | Reiterated | Bernstein | ||
| Michael Leuchten | 10/30/26 | EUR 100 | buy | 24.98%Upside | Reiterated | Jefferies | ||
| Richard Vosser | 10/30/26 | EUR 95 | hold | 18.74%Upside | Reiterated | J.P. Morgan | ||
| Unknown AnalystNot Ranked | 10/19/26 | EUR 94 | buy | 17.49%Upside | Reiterated | Leerink Partners | ||
| Matthew Weston | 10/15/26 | EUR 78 | hold | -2.51%Downside | Reiterated | UBS | ||
| Sachin Jain | 10/08/26 | EUR 92 | hold | 14.99%Upside | Reiterated | Bank of America Securities | ||
| Luisa Hector | 10/05/26 | EUR 105 | buy | 31.23%Upside | Reiterated | Berenberg Bank | ||
| Rajesh Kumar | 09/10/26 | EUR 95→EUR 100 | buy | 24.98%Upside | Reiterated | HSBC | ||
| Sarita Kapila | 08/11/26 | EUR 86→EUR 82 | hold | 2.49%Upside | Reiterated | Morgan Stanley | ||
| Elmar Kraus | 07/31/26 | ― | buy | ― | Reiterated | DZ BANK AG | ||
| James Quigley | 07/06/26 | EUR 89→EUR 84 | hold | 4.99%Upside | Reiterated | Goldman Sachs | ||
| Nicolas Pauillac | 04/23/26 | EUR 85 | hold | 6.24%Upside | Reiterated | Kepler Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Sanofi
3 Months
Success Rate15/26 ratings generated profit
58%
Average Return
+1.50%
Copying Luisa Hector's trades and holding each position for 3 Months would result in 57.69% of your transactions generating a profit, with an average return of +1.50% per trade.
1 Year
Success Rate20/35 ratings generated profit
57%
Average Return
+2.56%
Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.56% per trade.
2 Years
Success Rate15/26 ratings generated profit
58%
Average Return
+6.04%
Copying Florent Cespedes's trades and holding each position for 2 Years would result in 57.69% of your transactions generating a profit, with an average return of +6.04% per trade.
0O59 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 14 | 15 | 16 | 11 |
| Hold | 12 | 13 | 17 | 16 | 16 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 27 | 32 | 32 | 27 |
In the current month, 0O59 has received 11 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. 0O59 average Analyst price target in the past 3 months is 93.10.
0O59 Financial Forecast
HighEUR 2.11
ConsensusEUR 1.82
LowEUR 1.56
0O59 Earnings Forecast
Next quarter’s earnings estimate for 0O59 is EUR 1.82 with a range of EUR 1.56 to EUR 2.11. The previous quarter’s EPS was EUR 3.55. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 14B
ConsensusEUR 13.4B
LowEUR 12.8B
0O59 Sales Forecast
Next quarter’s sales forecast for 0O59 is EUR 13.37B with a range of EUR 12.77B to EUR 14.01B. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0O59 Stock Forecast FAQ
What is GB:0O59’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is €93.10.
What is GB:0O59’s upside potential, based on the analysts’ average price target?
Sanofi has 16.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is €93.10. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €106.21, and the lowest forecast is €78.00. The average share price target represents a 16.36% increase from the current price of €80.01.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of Sanofi?
To buy shares of GB:0O59, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
